JGC
PROK icon

J. Goldman & Co’s ProKidney PROK Stock Holding History

J. Goldman & Co’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-266,956
Closed -$2.64M – 427
2021
Q4 		$2.64M Hold
266,956
– – 0.15% 174
2021
Q3 		$2.62M Sell
266,956
-233,044
-47% -$2.29M 0.13% 172
2021
Q2 		$5.05M Buy
+500,000
New +$5.05M 0.2% 133

Other funds holding PROK

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

J. Goldman & Co's PROK Position: Q1 2022 in Review

J. Goldman & Co sold out of ProKidney (PROK) in Q1 2022, closing a stake of 266,956 shares — an estimated $2.64M sold.

J. Goldman & Co first reported a position in PROK in Q2 2021 and held it in 3 quarters. The position peaked at $5.05M in Q2 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.

  • J. Goldman & Co reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
  • J. Goldman & Co sold 266,956 ProKidney shares in Q1 2022, an estimated $2.64M.
  • J. Goldman & Co first reported a position in ProKidney in Q2 2021 and held it in 3 quarters.
  • J. Goldman & Co's ProKidney position peaked at $5.05M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.

Based on J. Goldman & Co's 13F filing for Q1 2022, filed 16 May 2022.